Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00726986 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped Extreme toxicity

Conditions

Lung Cancer

Interventions

DRUG: cisplatin
DRUG: etoposide
DRUG: sorafenib tosylate

Sponsor

Afshin Dowlati, MD

Collaborators

[object Object]